Activation of STAT3 through combined SRC and EGFR signaling drives resistance to a mitotic kinesin inhibitor in glioblastoma
胶质母细胞瘤中,STAT3通过SRC和EGFR信号通路的联合激活而产生对有丝分裂驱动蛋白抑制剂的耐药性。
期刊:Cell Reports
影响因子:7.5
doi:10.1016/j.celrep.2022.110991
Rajappa S Kenchappa,Athanassios Dovas,Michael G Argenziano,Christian T Meyer,Lauren E Stopfer,Matei A Banu,Brianna Pereira,Jessica Griffith,Afroz Mohammad,Surabhi Talele,Ashley Haddock,Natanael Zarco,William Elmquist,Forest White,Vito Quaranta,Peter Sims,Peter Canoll,Steven S Rosenfeld
信号转导
细胞生物学
信号转导
EGF
EGFR
SRC
STAT3